In a landmark move poised to redefine the approach to cardiometabolic health, the American Heart Association (AHA) has acquired the...
Cardiovascular
Folkerts, K. et al. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic...
In patients with type 2 diabetes (T2D) and chronic kidney disease (CKD), semaglutide reduced the risk of clinically important kidney...
In patients with type 2 diabetes and kidney disease, Ozempic (semaglutide) reduced kidney disease progression, major adverse cardiovascular events (MACE)...
